Market traction Prospection has secured over 100 life sciences clients and operates across 20+ therapeutic areas, signaling a proven demand for patient-centric intelligence and potential for upsell with expanded data offerings and AI-enabled products.

Executive leadership Recent high level appointments including a new non-executive chair and directors with deep pharma and tech expertise suggest strategic focus on governance, partnerships, and scaling in APAC and global markets.

Geographic expansion History of expanding offices to Japan and broader Eastern Asia indicates opportunity to tailor solutions for Japanese and regional pharma brands, enabling cross-border pilots and localized data capabilities.

Funding & growth Series B success and a total funding of around forty million USD demonstrate investor confidence and runway for product enhancements, new hires, and formal go-to-market expansion across regions.

Technology stack Utilization of industry-standard tools and analytics platforms implies readiness to integrate with customer tech stacks; potential cross-sell of advanced analytics, AI insights, and data enrichment services to commercial, medical, and analytics teams.